Tower Research Capital (TRC)’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,451
Closed -$343K 6917
2022
Q3
$343K Buy
16,451
+10,644
+183% +$222K 0.01% 1437
2022
Q2
$120K Buy
5,807
+3,992
+220% +$71K ﹤0.01% 2146
2022
Q1
$30K Buy
1,815
+888
+96% +$15.5K ﹤0.01% 3166
2021
Q4
$19K Sell
927
-9,725
-91% -$183K ﹤0.01% 3764
2021
Q3
$193K Buy
10,652
+7,359
+223% +$169K ﹤0.01% 1856
2021
Q2
$89K Sell
3,293
-15,199
-82% -$425K ﹤0.01% 2527
2021
Q1
$554K Buy
18,492
+14,454
+358% +$493K 0.01% 1157
2020
Q4
$116K Sell
4,038
-70,589
-95% -$1.91M ﹤0.01% 2204
2020
Q3
$1.82M Buy
74,627
+59,857
+405% +$1.29M 0.02% 452
2020
Q2
$265K Buy
+14,770
New +$194K 0.01% 1553
2020
Q1
Sell
-2,163
Closed -$29K 4222
2019
Q4
$29K Buy
2,163
+1,401
+184% +$17K ﹤0.01% 1691
2019
Q3
$9K Sell
762
-5,345
-88% -$98.9K ﹤0.01% 3028
2019
Q2
$150K Buy
6,107
+3,349
+121% +$96.5K 0.01% 990
2019
Q1
$88K Buy
+2,758
New +$97.9K 0.01% 1492

Other funds holding CVET

Tower Research Capital (TRC)'s CVET Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 16,451 shares — an estimated $343K sold.

Tower Research Capital (TRC) first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $1.82M in Q3 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 16,451 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $343K.
  • Tower Research Capital (TRC) first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s Covetrus, Inc. Common Stock position peaked at $1.82M in Q3 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.